Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitapivat in Regularly Transfused Adults with PK Deficiency
NCT03559699Phase 3Completed
- Sponsor
- Agios Pharmaceuticals
- Start
- Jun 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of mitapivat in pyruvate kinase deficiency (PKD), sponsored by Agios Pharmaceuticals. Started Jun 2018; status: completed.
02
Drugs
mitapivat
03
Conditions
pyruvate kinase deficiency (PKD)
Beyond the preview
Go deeper on NCT03559699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559699.